ALZCHEM GROUP AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.6 EUR | +1.25% |
|
-1.81% | +87.31% |
| Apr. 30 | Transcript : AlzChem Group AG, Q1 2024 Earnings Call, Apr 30, 2024 | |
| Apr. 30 | AlzChem Group AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2024 * | 566M 607M | Sales 2025 * | 595M 639M | Capitalization | 488M 525M |
|---|---|---|---|---|---|
| Net income 2024 * | 41M 44.03M | Net income 2025 * | 46M 49.4M | EV / Sales 2024 * | 0.92 x |
| Net Debt 2024 * | 31.4M 33.72M | Net Debt 2025 * | 38.83M 41.71M | EV / Sales 2025 * | 0.89 x |
| P/E ratio 2024 * |
11.7
x | P/E ratio 2025 * |
10.6
x | Employees | 1,607 |
| Yield 2024 * |
2.85% | Yield 2025 * |
3.13% | Free-Float | 99% |
More Fundamentals
* Assessed data
More news
Latest transcript on AlzChem Group AG
More press releases
More news
| 1 day | +0.83% | ||
| 1 week | +1.69% | ||
| Current month | -0.83% | ||
| 1 month | +14.29% | ||
| 3 months | +26.98% | ||
| 6 months | +83.21% | ||
| Current year | +84.62% |
1 week
47.20
49.60
1 month
39.5049.90
Current year
22.2049.90
1 year
18.1549.90
3 years
14.8049.90
5 years
11.0049.90
10 years
11.0050.82
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 17-10-01 | |
Andreas Losler
DFI | Director of Finance/CFO | - | 11-12-31 |
| Chief Operating Officer | 63 | 17-10-01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Markus Zöllner
CHM | Chairman | 56 | 17-08-03 |
Steve Röper
BRD | Director/Board Member | 48 | 17-10-01 |
| Director/Board Member | 51 | 17-08-03 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-03 | 48.7 | +1.46% | 2 194 |
| 24-07-02 | 48 | +0.63% | 1,021 |
| 24-07-01 | 47.7 | -1.45% | 2,366 |
| 24-06-28 | 48.4 | -0.41% | 5,339 |
| 24-06-27 | 48.6 | -2.02% | 10,441 |
Delayed Quote Xetra, July 02, 2024 at 11:36 am EDT
More quotes
Alzchem Group AG, fka AlzChem Group AG, is a Germany-based group parent company for a vertically integrated producer of chemical products based on the calcium carbide/calcium cyanamide chain. The Group's operating business is divided into three segments: Specialty Chemicals, Basics & Intermediates and Other & Holding. Its products can be applied in areas, such as nutrition, renewable energy, fine chemicals, agriculture and metallurgy. The Company produces dietary supplements; epoxy resin hardeners for use in adhesives, powder coatings, printed circuit boards and composites; silicon nitride for advanced ceramics and solar wafers; technical gases; specialty fertilizer, germicide for use in pig pens, plant growth regulators and plant protection additives, among others. It also provides related services. The Company operates production sites in Germany and Sweden, a sales subsidiary in the United States and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.
Sector
Diversified Chemicals
Calendar
2024-08-01
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
48
EUR
Average target price
52.15
EUR
Spread / Average Target
+8.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +84.62% | 524M | |
| +8.84% | 77.81B | |
| -8.32% | 42.85B | |
| +3.16% | 33.18B | |
| +13.54% | 18.8B | |
| +6.16% | 11.21B | |
| -24.06% | 9.8B | |
| -10.51% | 9.53B | |
| -1.97% | 8.8B | |
| -4.07% | 8.5B |
- Stock Market
- Equities
- ACT Stock
